These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38637229)

  • 21. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes.
    McCance DR; Hanson RL; Charles MA; Jacobsson LT; Pettitt DJ; Bennett PH; Knowler WC
    BMJ; 1994 May; 308(6940):1323-8. PubMed ID: 8019217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Longitudinal measure of glycemic control and diabetic retinopathy.
    Klein BE; Moss SE; Klein R
    Diabetes Care; 1987; 10(3):273-7. PubMed ID: 3297576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients.
    Shiraiwa T; Kaneto H; Miyatsuka T; Kato K; Yamamoto K; Kawashima A; Kanda T; Suzuki M; Imano E; Matsuhisa M; Hori M; Yamasaki Y
    Diabetes Care; 2005 Nov; 28(11):2806-7. PubMed ID: 16249562
    [No Abstract]   [Full Text] [Related]  

  • 24. An alternative approach to the diagnosis of diabetes with a review of the literature.
    Davidson MB; Peters AL; Schriger DL
    Diabetes Care; 1995 Jul; 18(7):1065-71. PubMed ID: 7555543
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of accelerated development of proliferative diabetic retinopathy in a woman with type 2 diabetes mellitus after pregnancy.
    Yam JP; Thai AC; Chua S; Chee C; Arulkumaran S
    Ann Acad Med Singap; 1998 Mar; 27(2):265-8. PubMed ID: 9663323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
    Wareham NJ; Pfister R
    Nat Rev Cardiol; 2010 Jul; 7(7):367-8. PubMed ID: 20577298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward a Better Understanding of Diabetes Risk.
    Preston AM
    P R Health Sci J; 2020 Mar; 39(1):3-4. PubMed ID: 32383561
    [No Abstract]   [Full Text] [Related]  

  • 28. Is HbA1c an ideal biomarker of well-controlled diabetes?
    Kaiafa G; Veneti S; Polychronopoulos G; Pilalas D; Daios S; Kanellos I; Didangelos T; Pagoni S; Savopoulos C
    Postgrad Med J; 2021 Jun; 97(1148):380-383. PubMed ID: 32913038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Worsening of diabetic retinopathy with rapid improvement in systemic glucose control: A review.
    Bain SC; Klufas MA; Ho A; Matthews DR
    Diabetes Obes Metab; 2019 Mar; 21(3):454-466. PubMed ID: 30226298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postprandial hyperglycaemia--its importance and implications.
    Lüddeke HJ
    Int J Clin Pract Suppl; 1999 Jul; 104():3-7; discussion 18-20. PubMed ID: 12669731
    [No Abstract]   [Full Text] [Related]  

  • 31. Regarding the role of growth hormone in the development of diabetic retinopathy.
    McGowan LM; Kiser WR
    Diabetes Care; 1995 Mar; 18(3):422-3. PubMed ID: 7555494
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship of hemoglobin A1c with the presence and severity of retinopathy upon initial screening of type II diabetes mellitus.
    Cheung N; Wang JJ; Wong TY; Mitchell P; Klein R
    Am J Ophthalmol; 2007 Oct; 144(4):639-40; author reply 640. PubMed ID: 17893018
    [No Abstract]   [Full Text] [Related]  

  • 33. Correlation of serum delta-like ligand-4 level with the severity of diabetic retinopathy.
    Zhu Y; Hu J; Du X; Fang Q; Zhou Y; Chen K
    BMC Endocr Disord; 2021 Aug; 21(1):157. PubMed ID: 34362349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 'Hard,' 'soft' and 'surrogate' endpoints in diabetes.
    Yudkin JS; Eggleston EM
    J Epidemiol Community Health; 2013 Apr; 67(4):295-7. PubMed ID: 23172608
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum Pentraxin 3 level as a recent biomarker of diabetic retinopathy in Egyptian patients with diabetes.
    Elbana KA; Salem HM; Abdel Fattah NR; Etman E
    Diabetes Metab Syndr; 2019; 13(4):2361-2364. PubMed ID: 31405644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [More than diabetics?].
    Trivin F
    Ann Biol Clin (Paris); 1998; 56(4):385-6. PubMed ID: 9841575
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of hemoglobin A1c and fasting plasma glucose to diagnose type 2 diabetes in the real world.
    Nayak BS; Mungrue K; Seepersad S; Sookram J; Singh S; Skeete C; Samaroo C; Seebalack V; Siraramsingh N; Sharma M
    J Diabetes Sci Technol; 2012 May; 6(3):721-2. PubMed ID: 22768907
    [No Abstract]   [Full Text] [Related]  

  • 38. Deterioration of glycemic control after long-term treatment with troglitazone in nonobese type 2 diabetic patients.
    Murase Y; Wakasugi T; Yagi K; Mabuchi H
    Diabetes Care; 2000 Jan; 23(1):131-2. PubMed ID: 10857989
    [No Abstract]   [Full Text] [Related]  

  • 39. Glycated hemoglobin A1C level and the risk of diabetic retinopathy in Africa: A systematic review and meta-analysis.
    Shiferaw WS; Akalu TY; Desta M; Kassie AM; Petrucka PM; Assefa HK; Aynalem YA
    Diabetes Metab Syndr; 2020; 14(6):1941-1949. PubMed ID: 33039936
    [TBL] [Abstract][Full Text] [Related]  

  • 40.  How to screen NAFLD patients for diabetes?
    González-Moreno EI; García-Compean D; González-González JA; Maldonado-Garza HJ
    Ann Hepatol; 2016; 15(5):801-2. PubMed ID: 27493121
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.